|
ISEV Board Financial Disclosures
Elected members of the ISEV Board of Directors are required to report any relevant financial relationships with industry. This is done on an annual basis, and leaders are asked to report any new relationships as soon as they arise.
The following leaders reported the following relevant financial relationships. These disclosures were reviewed and no relationships were found to present a conflict of interest:
- Benedetta Bussolati, Addax Biosciences (Co-Founder/Board Member), Eris Biotech (Consultant)
- Randy Carney, Allumbra (Co-Founder/CSO)
- Naveed Akbar, Novo Nordisk (fellowship program support), Vesiculab (supervisor to supported PhD studentship)
- Kenneth Witwer, Novadip Biosciences SA (Advisory Board), Libera (Advisory Board), B4-RNA (Advisor); holds stock options for Neurodex; have several patents and patent applications related to extracellular vesicles; consulting in the extracellular RNA and EV areas as Kenneth Witwer Consulting
- Antonella Bongiovanni, EVEBiofactory SRL (Co-Founder/Board Member)
- Monica Ng, Boehringer Ingelheim (Consulting Compensation)
The following leaders had no financial relationships to report:
- Mỹ Mahoney
- Andreas Möller
- Dylan Burger
- Carlos Salomon
- An Hendrix
- Carlos Jesus
- Christian Neri
- Dong Jun Park
- Lorena Martin Jaular
- Matias Ostrowski
- Mei He
- Mona Batish
- Natalie Turner
- Yiyao Huang
- Yu Fujita
Last updated spring 2026
|
